I’m Gaetano, born and raised in Newark, NJ. I’m an advocate and researcher for social justice, cannabis, and psychedelics. I worked for over 25 years in cancer research with thousands of cancer patients and medical professionals internationally. I used to be a suit & tie guy, supervising MDs and PhDs, and yes, I used to work in pharmaceuticals. So, what changed? What inspired me to break away and get into cannabis? Well, I saw a need for patient care for those diagnosed with cancer. I met these patients, and they strongly advocated for medicinal marijuana use. My heartfelt breaks for these patients and for the communities like mine of Newark NJ that have been devastated by the so-called “war-on-drugs!”
Moving forward I have spent the last several years advocating for cannabis and psychedelic research and social justice. So, I made a career change to break away from what I was currently doing professionally and put my 44 years of experience in the medical field and my skills to advocate for social justice and research. From there, I supported a network of patient care individuals to justice-involved cannabis professionals and partnered with organizations such as CMMNJ, Stockton, Minorities 4 Medical Marijuana, etc.
Currently, I serve as the Special Executive Advisor for F.E.M. where we explore uses for all plant medicines and we propel research with grace, science, and strategy. In one of our more recent endeavors, we are in preliminary discussions to test plant medicines including CBD and other Psychedelics in deep space before the end of 2023. Stay tuned.
The best part about this industry is the growing community. If you’re new to the sphere and you’re overwhelmed with all the events and notifications, we can always chat and I can tell you about the events that might best fit your interest. What’s so amazing is that over the years, I have made so many friends and got to watch those I knew grow and succeed!
All the Best,
Gaetano
Founder and CEO of Supersonic Biotech SA, Switzerland, Thomas is specialized in innovative delivery systems for active compounds, with RD and all processes and protocols established in collaboration with the Centre National de Recherches Scientifiques and the University of Savoie Mont Blanc.
30+ yr of experience in Aerospace Medicine, Space Physiology, Telemedicine & Digital Health. She is an MD from Brazil, specializing in internal medicine, and has an MSc in Aerospace Medicine (USA) and a PhD in Space Physiology from King’s College London (UK). She worked for 3 years as a researcher at DLR, Germany, before establishing and
30+ yr of experience in Aerospace Medicine, Space Physiology, Telemedicine & Digital Health. She is an MD from Brazil, specializing in internal medicine, and has an MSc in Aerospace Medicine (USA) and a PhD in Space Physiology from King’s College London (UK). She worked for 3 years as a researcher at DLR, Germany, before establishing and coordinating the Microgravity Centre, PUCRS for 18 years. She is academically linked to several universities, such as King's College London-UK, University of Lisbon-Portugal, Carol Davila Univ of Med and Pharmacy-Romania, and UFCSPA-Brazil. This is an Elected Academician of the International Academy of Aviation and Space Medicine, and the International Academy of Astronautics (Board of Trustees).
A scientist with wide experience in both academic and private biotech research. Co-founder of SenCell Therapeutic. Specialist of cellular senescence/ aging, cancer, and immunotherapy. Scientific publications include covid/ cellular senescence, cellular senescence, immunotherapy/ vaccines, cancer, and DNA damage. Co-author of the book of the CSIC, "Space Colonization and Exploration".
Mr. Kanoui is the CEO of Swiss NanoTech and possesses a long history of entrepreneurship in various industries such as jewelry, tobacco, oil &commodities, and pharmaceuticals. Has served several large companies in various top managerial positions and as CEO. As such, has acquired great experience and global networking within East and West Europe, the Middle East, Asia, and South America.
Copyright © 2023 FEM - All Rights Reserved.